The risk or severity of adverse effects can be increased when rescinnamine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when loteprednol is combined with cinoxacin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Articaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when alprostadil is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with MEGESTROL ACETATE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with thioguanine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with aminoglutethimide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when nimesulide is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Olopatadine is combined with amcinonide.


The risk or severity of adverse effects can be increased when Almasilate is combined with misoprostol.


The risk or severity of adverse effects can be increased when nimesulide is combined with prednisone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Etidocaine is combined with primidone.


The risk or severity of adverse effects can be increased when Clofarabine is combined with imipramine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with nefazodone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when alprenolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with papaverine.


The risk or severity of adverse effects can be increased when Perospirone is combined with brotizolam.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with dexamethasone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with flumethasone.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with salicylamide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nisoldipine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Articaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Telmisartan is combined with rescinnamine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when docetaxel is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Amrinone.


The risk or severity of adverse effects can be increased when loxapine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when loxapine is combined with triazolam.


The risk or severity of adverse effects can be increased when METAXALONE is combined with zonisamide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when clotrimazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Clobetasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Naftifine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with clozapine.


The risk or severity of adverse effects can be increased when Naftifine is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Naftifine is combined with Halobetasol.


The risk or severity of adverse effects can be increased when ondansetron is combined with tiagabine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with selegiline.


The risk or severity of adverse effects can be increased when ketamine is combined with tiapride.


The risk or severity of adverse effects can be increased when Butethal is combined with primidone.


The risk or severity of adverse effects can be increased when methocarbamol is combined with sertraline.


The risk or severity of adverse effects can be increased when Telmisartan is combined with diclofenac.


The risk or severity of adverse effects can be increased when Telmisartan is combined with enalapril.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Perospirone.


The risk or severity of adverse effects can be increased when captopril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when medrysone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with clidinium.


The risk or severity of adverse effects can be increased when Boceprevir is combined with oxycodone.


The risk or severity of adverse effects can be increased when apomorphine is combined with barnidipine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with vinblastine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when trichlormethiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when lithium ion is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when methadone is combined with zotepine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with citalopram.


The risk or severity of adverse effects can be increased when fosinopril is combined with D-mannitol.


The risk or severity of adverse effects can be increased when indomethacin is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when fosinopril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when azelastine is combined with prednisone.


The risk or severity of adverse effects can be increased when fosinopril is combined with etodolac.


The risk or severity of adverse effects can be increased when clotiazepam is combined with atorvastatin.


The risk or severity of adverse effects can be increased when ticlopidine is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when terazosin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when terazosin is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when promazine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Pentolinium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with halcinonide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Nabilone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with difluprednate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nicardipine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with clomipramine.


The risk or severity of adverse effects can be increased when promazine is combined with butalbital.


The risk or severity of adverse effects can be increased when codeine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with enalapril.


The risk or severity of adverse effects can be increased when perphenazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when spironolactone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with equilin.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with tubocurarine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with antipyrine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with sertraline.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Metixene.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when ATROPINE is combined with pancuronium.


The risk or severity of adverse effects can be increased when ATROPINE is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when temazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with nimodipine.


The risk or severity of adverse effects can be increased when salicylamide is combined with triamcinolone.


The risk or severity of adverse effects can be increased when nimodipine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when procyclidine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with primidone.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Pipamperone is combined with tolazoline.


The risk or severity of adverse effects can be increased when Pipamperone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when moclobemide is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when butalbital is combined with citalopram.


The risk or severity of adverse effects can be increased when metaraminol is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when tropicamide is combined with pancuronium.


The risk or severity of adverse effects can be increased when protriptyline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when HEROIN is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when clemastine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ketamine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when ketamine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when secobarbital is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when temazepam is combined with Normethadone.


The risk or severity of adverse effects can be increased when naratriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when tropicamide is combined with oxymorphone.


The risk or severity of adverse effects can be increased when clidinium is combined with primidone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when tretinoin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with etizolam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Fospropofol.


The risk or severity of adverse effects can be increased when triazolam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with vigabatrin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with dyclonine.


The risk or severity of adverse effects can be increased when aspirin is combined with acemetacin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when thiamylal is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when cabergoline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when thiamylal is combined with flunarizine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Icatibant.


The risk or severity of adverse effects can be increased when propofol is combined with tiapride.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when risperidone is combined with Etidocaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when olanzapine is combined with Melatonin.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Lapatinib.


The risk or severity of adverse effects can be increased when fludiazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with dantrolene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with tiapride.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with flunisolide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Milnacipran.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Melatonin.


The risk or severity of adverse effects can be increased when clozapine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when ketorolac is combined with diflorasone.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with lidocaine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when fenbufen is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when ibuprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when levorphanol is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when ethanol is combined with Phenelzine.


The risk or severity of adverse effects can be increased when lidocaine is combined with promethazine.


The risk or severity of adverse effects can be increased when lidocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when promethazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with methazolamide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with hydromorphone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with budesonide.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with trimipramine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with haloperidol.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when efavirenz is combined with trimipramine.


The risk or severity of adverse effects can be increased when nicardipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when methysergide is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Melatonin is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when mesoridazine is combined with amoxapine.


The risk or severity of adverse effects can be increased when sulindac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when HEROIN is combined with potassium ion.


The risk or severity of adverse effects can be increased when SOMATOSTATIN is combined with phenobarbital.


The risk or severity of adverse effects can be increased when METAXALONE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when nicergoline is combined with bromocriptine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with Apremilast.


The risk or severity of adverse effects can be increased when Olopatadine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Perospirone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Etomidate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when ethotoin is combined with levodopa.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Sacubitril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Pipamperone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when etizolam is combined with topiramate.


The risk or severity of adverse effects can be increased when Sacubitril is combined with salicylic acid.


The risk or severity of adverse effects can be increased when metolazone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Pipazethate.


The risk or severity of adverse effects can be increased when metolazone is combined with felodipine.


The risk or severity of adverse effects can be increased when pramipexole is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when metolazone is combined with ouabain.


The risk or severity of adverse effects can be increased when pramipexole is combined with Metipranolol.


The risk or severity of adverse effects can be increased when methysergide is combined with ketoconazole.


The risk or severity of adverse effects can be increased when pramipexole is combined with Aliskiren.


The risk or severity of adverse effects can be increased when doxazosin is combined with Metipranolol.


The risk or severity of adverse effects can be increased when antipyrine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when procyclidine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when methylergonovine is combined with metronidazole.


The risk or severity of adverse effects can be increased when procaine is combined with clemastine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Agomelatine.


The risk or severity of adverse effects can be increased when procaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Propacetamol is combined with betamethasone.


The risk or severity of adverse effects can be increased when moclobemide is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Normethadone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when floctafenine is combined with betamethasone.


The risk or severity of adverse effects can be increased when Idelalisib is combined with oxycodone.


The risk or severity of adverse effects can be increased when amisulpride is combined with Flibanserin.


The risk or severity of adverse effects can be increased when butorphanol is combined with HEROIN.


The risk or severity of adverse effects can be increased when bromazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when citalopram is combined with duloxetine.


The risk or severity of adverse effects can be increased when tolterodine is combined with pentazocine.


The risk or severity of adverse effects can be increased when diclofenac is combined with ketoprofen.


The risk or severity of adverse effects can be increased when dyclonine is combined with Butethal.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with tetracaine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with meclizine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when mesalamine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when proparacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when benztropine is combined with butorphanol.


The risk or severity of adverse effects can be increased when protriptyline is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when quazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when clozapine is combined with hydralazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when desipramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when HEROIN is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when HEROIN is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when apomorphine is combined with irbesartan.


The risk or severity of adverse effects can be increased when amoxapine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when mecamylamine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when leflunomide is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when leflunomide is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when HEROIN is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when dyclonine is combined with Normethadone.


The risk or severity of adverse effects can be increased when sulconazole is combined with simvastatin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Efonidipine.


The risk or severity of adverse effects can be increased when diflunisal is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when diflunisal is combined with Droxicam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with efavirenz.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with thioridazine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with losartan.


The risk or severity of adverse effects can be increased when halothane is combined with rasagiline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with ethanol.


The risk or severity of adverse effects can be increased when indapamide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when barnidipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Conivaptan is combined with isoflurane.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when vinorelbine is combined with mitomycin C.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when thiamylal is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when prednisone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when prednisone is combined with galanthamine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with linezolid.


The risk or severity of adverse effects can be increased when oxycodone is combined with Perospirone.


The risk or severity of adverse effects can be increased when Torasemide is combined with Riociguat.


The risk or severity of adverse effects can be increased when meperidine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when chloroquine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when flunisolide is combined with ambenonium.


The risk or severity of adverse effects can be increased when diclofenac is combined with Apremilast.


The risk or severity of adverse effects can be increased when pentamidine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when equilin is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when ketorolac is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when nalbuphine is combined with clemastine.


The risk or severity of adverse effects can be increased when resveratrol is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with cilazapril.


The risk or severity of adverse effects can be increased when lisinopril is combined with suprofen.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with dibucaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when clorazepate is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with methadone.


The risk or severity of adverse effects can be increased when Remikiren is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when tizanidine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when sulpiride is combined with Retigabine.


The risk or severity of adverse effects can be increased when clorazepate is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with epirizole.


The risk or severity of adverse effects can be increased when HEROIN is combined with tiapride.


The risk or severity of adverse effects can be increased when diclofenac is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when propofol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with niflumic acid.


The risk or severity of adverse effects can be increased when selegiline is combined with nifedipine.


The risk or severity of adverse effects can be increased when estazolam is combined with HEROIN.


The risk or severity of adverse effects can be increased when sevoflurane is combined with dibucaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with metolazone.


The risk or severity of adverse effects can be increased when prazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with etizolam.


The risk or severity of adverse effects can be increased when tizanidine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sevoflurane is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with furosemide.


The risk or severity of adverse effects can be increased when quinidine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Mirabegron.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with METAXALONE.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Trospium.


The risk or severity of adverse effects can be increased when fluoxetine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when Butethal is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when doxepin is combined with Indacaterol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Metipranolol is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when methylene blue is combined with thiopental.


The risk or severity of adverse effects can be increased when floctafenine is combined with tenoxicam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with lisinopril.


The risk or severity of adverse effects can be increased when oxymorphone is combined with dibucaine.


The risk or severity of adverse effects can be increased when floctafenine is combined with ketorolac.


The risk or severity of adverse effects can be increased when oxymorphone is combined with metolazone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with penbutolol.


The risk or severity of adverse effects can be increased when floctafenine is combined with nabumetone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when lorazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when pergolide is combined with irinotecan.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when imipramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with pancuronium.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when tolmetin is combined with paramethasone.


The risk or severity of adverse effects can be increased when alclofenac is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when benzocaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with tofisopam.


The risk or severity of adverse effects can be increased when secobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when prilocaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when dyclonine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when prilocaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when pentazocine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Icatibant is combined with alclofenac.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with prednisone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with fluoxetine.


The risk or severity of adverse effects can be increased when SIMEPREVIR is combined with mecamylamine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with duloxetine.


The risk or severity of adverse effects can be increased when quinidine is combined with topiramate.


The risk or severity of adverse effects can be increased when methysergide is combined with losartan.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when tretinoin is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when diltiazem is combined with losartan.


The risk or severity of adverse effects can be increased when celecoxib is combined with formestane.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Agomelatine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when zaleplon is combined with butalbital.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when temazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when butabarbital is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when butabarbital is combined with meprobamate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with podophyllotoxin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Iloperidone.


The risk or severity of adverse effects can be increased when benzoic acid is combined with felodipine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with IDARUBICIN.


The risk or severity of adverse effects can be increased when Naftifine is combined with Benidipine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Telaprevir is combined with lidocaine.


The risk or severity of adverse effects can be increased when diflorasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with formestane.


The risk or severity of adverse effects can be increased when indomethacin is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when nisoldipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with tiapride.


The risk or severity of adverse effects can be increased when trandolapril is combined with doxazosin.


The risk or severity of adverse effects can be increased when doxepin is combined with Arformoterol.


The risk or severity of adverse effects can be increased when benzocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when trandolapril is combined with labetalol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with leflunomide.


The risk or severity of adverse effects can be increased when doxazosin is combined with lisinopril.


The risk or severity of adverse effects can be increased when isradipine is combined with trandolapril.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with zopiclone.


The risk or severity of adverse effects can be increased when epirizole is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with diazepam.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when ATROPINE is combined with topiramate.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with prednisone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with promethazine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when propranolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when bromazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when bromazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with triamterene.


The risk or severity of adverse effects can be increased when Droxicam is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Almotriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when glutethimide is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when pergolide is combined with diazepam.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with topiramate.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when meperidine is combined with etizolam.


The risk or severity of adverse effects can be increased when linezolid is combined with pimozide.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with Spirapril.


The risk or severity of adverse effects can be increased when celecoxib is combined with carprofen.


The risk or severity of adverse effects can be increased when duloxetine is combined with nefazodone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with glutethimide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with zotepine.


The risk or severity of adverse effects can be increased when oxazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when oxazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Torasemide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when isoflurane is combined with Torasemide.


The risk or severity of adverse effects can be increased when Triflusal is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Echothiophate is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Echothiophate is combined with nicotine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with sertraline.


The risk or severity of adverse effects can be increased when clonazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when quazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when quazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when Echothiophate is combined with Varenicline.


The risk or severity of adverse effects can be increased when Nepafenac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Salsalate is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when etodolac is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when prazosin is combined with metolazone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with metolazone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Agomelatine is combined with etizolam.


The risk or severity of adverse effects can be increased when captopril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Sacubitril.


The risk or severity of adverse effects can be increased when chlorambucil is combined with leflunomide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when imipramine is combined with nimodipine.


The risk or severity of adverse effects can be increased when meperidine is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when medrysone is combined with decamethonium.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when epinephrine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nimodipine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with potassium ion.


The risk or severity of adverse effects can be increased when etodolac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when mesalamine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when perphenazine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when perphenazine is combined with Etomidate.


The risk or severity of adverse effects can be increased when alprazolam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with tizanidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with tretinoin.


The risk or severity of adverse effects can be increased when epoprostenol is combined with isoflurane.


The risk or severity of adverse effects can be increased when halcinonide is combined with donepezil.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when lithium ion is combined with levodopa.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with cetirizine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with azelastine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Tiotropium is combined with pentazocine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with ILOPROST.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with nefazodone.


The risk or severity of adverse effects can be increased when butamben is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when quinapril is combined with captopril.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when quinapril is combined with acebutolol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with flunarizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with zopiclone.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with protriptyline.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with buprenorphine.


The risk or severity of adverse effects can be increased when tetrahydrozoline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with cetirizine.


The risk or severity of adverse effects can be increased when celecoxib is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when apraclonidine is combined with irbesartan.


The risk or severity of adverse effects can be increased when codeine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Tapentadol is combined with periciazine.


The risk or severity of adverse effects can be increased when reserpine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with glutethimide.


The risk or severity of adverse effects can be increased when buspirone is combined with midazolam.


The risk or severity of adverse effects can be increased when zopiclone is combined with halothane.


The risk or severity of adverse effects can be increased when Artemether is combined with nimesulide.


The risk or severity of adverse effects can be increased when zopiclone is combined with thiamylal.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with D-mannitol.


The risk or severity of adverse effects can be increased when zopiclone is combined with desipramine.


The risk or severity of adverse effects can be increased when codeine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with bumetanide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with quinapril.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when nicergoline is combined with tamoxifen.


The risk or severity of adverse effects can be increased when Icatibant is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when ATROPINE is combined with tropicamide.


The risk or severity of adverse effects can be increased when pentamidine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Normethadone.


The risk or severity of adverse effects can be increased when brotizolam is combined with scopolamine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Tianeptine is combined with furazolidone.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with bumetanide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Ramelteon is combined with promethazine.


The risk or severity of adverse effects can be increased when Ramelteon is combined with clonazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with spironolactone.


The risk or severity of adverse effects can be increased when reserpine is combined with promazine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when oxaprozin is combined with diflorasone.


The risk or severity of adverse effects can be increased when reserpine is combined with triprolidine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Crizotinib.


The risk or severity of adverse effects can be increased when Arotinolol is combined with cilazapril.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when thiothixene is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when epoprostenol is combined with ILOPROST.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with bupropion.


The risk or severity of adverse effects can be increased when spiramycin is combined with fluvastatin.


The risk or severity of adverse effects can be increased when amcinonide is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Tramadol is combined with clorazepate.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with quinapril.


The risk or severity of adverse effects can be increased when tubocurarine is combined with pentazocine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with bumetanide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with zopiclone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with captopril.


The risk or severity of adverse effects can be increased when buspirone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when amcinonide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when buspirone is combined with benzocaine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when olanzapine is combined with meclizine.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when efavirenz is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with topiramate.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Remoxipride.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with loxapine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with hydralazine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with dicyclomine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with zonisamide.


The risk or severity of adverse effects can be increased when oxaprozin is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Halobetasol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Etidocaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when cabergoline is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when amifostine is combined with thioridazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with cocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with tiagabine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with flunisolide.


The risk or severity of adverse effects can be increased when lorazepam is combined with gabapentin.


The risk or severity of adverse effects can be increased when ondansetron is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when barnidipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when barnidipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Carbetocin is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Toloxatone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Pirlindole.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with duloxetine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with PONATINIB.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with azelastine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with formestane.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when pentazocine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when rasagiline is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with barnidipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with morphine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with bupivacaine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when methysergide is combined with methimazole.


The risk or severity of adverse effects can be increased when fenoprofen is combined with aspirin.


The risk or severity of adverse effects can be increased when ramipril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with protriptyline.


The risk or severity of adverse effects can be increased when diazepam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trazodone is combined with meclizine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with protriptyline.


The risk or severity of adverse effects can be increased when loratadine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when thiothixene is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with metoprolol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with clorazepate.


The risk or severity of adverse effects can be increased when thiothixene is combined with Pramocaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with papaverine.


The risk or severity of adverse effects can be increased when ramipril is combined with fenbufen.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ropinirole.


The risk or severity of adverse effects can be increased when mecamylamine is combined with cilazapril.


The risk or severity of adverse effects can be increased when alprazolam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when tiagabine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when alprazolam is combined with sulpiride.


The risk or severity of adverse effects can be increased when tiagabine is combined with duloxetine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with losartan.


The risk or severity of adverse effects can be increased when ILOPROST is combined with tretinoin.


The risk or severity of adverse effects can be increased when trazodone is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with isoflurane.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with periciazine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Salsalate.


The risk or severity of adverse effects can be increased when levorphanol is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when nabumetone is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when clorazepate is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when carprofen is combined with salicylamide.


The risk or severity of adverse effects can be increased when levorphanol is combined with selegiline.


The risk or severity of adverse effects can be increased when paroxetine is combined with Tianeptine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with enalapril.


The risk or severity of adverse effects can be increased when clozapine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Pirlindole is combined with clenbuterol.


The risk or severity of adverse effects can be increased when clozapine is combined with glutethimide.


The risk or severity of adverse effects can be increased when Voriconazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nadolol is combined with Riociguat.


The risk or severity of adverse effects can be increased when Pirlindole is combined with Bambuterol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Mersalyl.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when dibucaine is combined with cocaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when Darunavir is combined with meperidine.


The risk or severity of adverse effects can be increased when Talniflumate is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with Naftifine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with oxprenolol.


The risk or severity of adverse effects can be increased when sertraline is combined with Tapentadol.


The risk or severity of adverse effects can be increased when amphotericin b is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with prazepam.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when trazodone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Metipranolol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with leflunomide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with cetirizine.


The risk or severity of adverse effects can be increased when trazodone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when codeine is combined with Mersalyl.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with maprotiline.


The risk or severity of adverse effects can be increased when josamycin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when morphine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when zopiclone is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when ibuprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when perphenazine is combined with butamben.


The risk or severity of adverse effects can be increased when ibuprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with citalopram.


The risk or severity of adverse effects can be increased when betamethasone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when pimozide is combined with topiramate.


The risk or severity of adverse effects can be increased when lisinopril is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with clidinium.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when rasagiline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when ketorolac is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when triprolidine is combined with clomipramine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Spirapril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when Trabectedin is combined with leflunomide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with etoposide.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Droxicam.


The risk or severity of adverse effects can be increased when cocaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when amobarbital is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when procarbazine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when methadone is combined with linezolid.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Pramocaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with benzocaine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Lurasidone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with theobromine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ticlopidine is combined with mesalamine.


The risk or severity of adverse effects can be increased when halothane is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dyclonine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with salicylic acid.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with mestranol.


The risk or severity of adverse effects can be increased when oxaprozin is combined with Apremilast.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Tramadol.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when atenolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with protriptyline.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Agomelatine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tetracaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when naratriptan is combined with amisulpride.


The risk or severity of adverse effects can be increased when Talniflumate is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Halazepam.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with benazepril.


The risk or severity of adverse effects can be increased when Torasemide is combined with Spectinomycin.


The risk or severity of adverse effects can be increased when docetaxel is combined with vincristine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with primidone.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with bepridil.


The risk or severity of adverse effects can be increased when docetaxel is combined with 5-Fluorouracil.


The risk or severity of adverse effects can be increased when docetaxel is combined with azelaic acid.


The risk or severity of adverse effects can be increased when Articaine is combined with Normethadone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Tramadol.


The risk or severity of adverse effects can be increased when miconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when methadone is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when imipramine is combined with clomipramine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with bumetanide.


The risk or severity of adverse effects can be increased when imipramine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CABAZITAXEL.


The risk or severity of adverse effects can be increased when promazine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when promazine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when promazine is combined with triazolam.


The risk or severity of adverse effects can be increased when ticlopidine is combined with diflunisal.


The risk or severity of adverse effects can be increased when lithium ion is combined with efavirenz.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Olmesartan is combined with leflunomide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Indacaterol.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with nimesulide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with propofol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with linezolid.


The risk or severity of adverse effects can be increased when sulindac is combined with Olopatadine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Tramadol.


The risk or severity of adverse effects can be increased when minoxidil is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when oxycodone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when thiamylal is combined with butalbital.


The risk or severity of adverse effects can be increased when methadone is combined with bumetanide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with bromazepam.


The risk or severity of adverse effects can be increased when lorazepam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with butamben.


The risk or severity of adverse effects can be increased when alprenolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when haloperidol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Etomidate is combined with dantrolene.


The risk or severity of adverse effects can be increased when Perospirone is combined with zotepine.


The risk or severity of adverse effects can be increased when Perospirone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when risperidone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Melatonin is combined with vigabatrin.


The risk or severity of adverse effects can be increased when topiramate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with oxymorphone.


The risk or severity of adverse effects can be increased when docetaxel is combined with Amrubicin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with budesonide.


The risk or severity of adverse effects can be increased when prilocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when protriptyline is combined with Pizotifen.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when secobarbital is combined with dibucaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with desipramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with codeine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with thiamylal.


The risk or severity of adverse effects can be increased when methysergide is combined with sulfisoxazole.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with leflunomide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Bretylium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with halothane.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with apraclonidine.


The risk or severity of adverse effects can be increased when tolmetin is combined with budesonide.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when zotepine is combined with primidone.


The risk or severity of adverse effects can be increased when thiopental is combined with clidinium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nisoldipine.


The risk or severity of adverse effects can be increased when alclometasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when bepridil is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Tadalafil is combined with alprostadil.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Remoxipride.


The risk or severity of adverse effects can be increased when triazolam is combined with Articaine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Droxicam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Droxicam is combined with haloperidol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when meperidine is combined with zotepine.


The risk or severity of adverse effects can be increased when meperidine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when butabarbital is combined with zotepine.


The risk or severity of adverse effects can be increased when aspirin is combined with Tixocortol.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when loteprednol is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when Melatonin is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Spirapril is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when prilocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when terconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when prilocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when losartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when Melatonin is combined with meclizine.


The risk or severity of adverse effects can be increased when loxapine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when nabumetone is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when haloperidol is combined with enflurane.


The risk or severity of adverse effects can be increased when Pipamperone is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when reserpine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when isoflurane is combined with METAXALONE.


The risk or severity of adverse effects can be increased when isoflurane is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when phenobarbital is combined with MELPERONE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with HEROIN.


The risk or severity of adverse effects can be increased when nimodipine is combined with bumetanide.


The risk or severity of adverse effects can be increased when lidocaine is combined with topiramate.


The risk or severity of adverse effects can be increased when nimodipine is combined with quinapril.


The risk or severity of adverse effects can be increased when nimodipine is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with budesonide.


The risk or severity of adverse effects can be increased when temazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when bupivacaine is combined with doxepin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with amcinonide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when procaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Vecuronium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when benazepril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when procaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when dopamine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when benazepril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with clozapine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when Butethal is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Butethal is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Eprosartan.


The risk or severity of adverse effects can be increased when triflupromazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when fosinopril is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with butamben.


The risk or severity of adverse effects can be increased when ketamine is combined with lithium ion.


The risk or severity of adverse effects can be increased when flurazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with tirofiban.


The risk or severity of adverse effects can be increased when ketamine is combined with Butethal.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with alprostadil.


The risk or severity of adverse effects can be increased when ketamine is combined with amobarbital.


The risk or severity of adverse effects can be increased when procarbazine is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Atomoxetine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when flurazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when levodopa is combined with Toloxatone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when Almotriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when amiodarone is combined with amphotericin b.


The risk or severity of adverse effects can be increased when sulconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Flibanserin.


The risk or severity of adverse effects can be increased when fluocinonide is combined with physostigmine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when fenbufen is combined with Mometasone.


The risk or severity of adverse effects can be increased when fluocinonide is combined with rivastigmine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with pentazocine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when quinidine is combined with orphenadrine.


The risk or severity of adverse effects can be increased when etizolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with terazosin.


The risk or severity of adverse effects can be increased when valsartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when phenytoin is combined with triprolidine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when triazolam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when triazolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Halobetasol is combined with memantine.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with toremifene.


The risk or severity of adverse effects can be increased when tolnaftate is combined with nicardipine.


The risk or severity of adverse effects can be increased when SAQUINAVIR is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Etomidate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when amisulpride is combined with Olopatadine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with dipyridamole.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Olopatadine.


The risk or severity of adverse effects can be increased when propofol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with clonidine.


The risk or severity of adverse effects can be increased when ketamine is combined with ethotoin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with isoxsuprine.